Opendata, web and dolomites

CLINICOVERY SIGNED

CLINICOVERY, a versatile, high quality, environmental-friendly, easy to use e-Clinical solution for clinical research

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 CLINICOVERY project word cloud

Explore the words cloud of the CLINICOVERY project. It provides you a very rough idea of what is the project "CLINICOVERY" about.

complicate    provides    33    upgrades    regulatory    pharmaceutical    fda    million    2024    chemical    public    less    trials    remarkable    asia    electronic    compliance    huge    generating    accumulative    capture    highest    burden    rate    agencies    quantum    region    reduce    returns    roi    biomedical    private    2020    monitoring    investment    16    gains    platform    market    pacific    cloud    entities    pencil    cagr    edc    maintenance    multiple    expenses    markets    clinical    99    clinicovery    data    versatile    physiological    capability    obtaining    gives    adverse    participating    warning    disease    create    paper    propelled    travels    faster    45    yields    endpoints    outputs    time    contains    health    medical    approval    administrative    price    stakeholders    2015    countries    sectors    modalities    performing    industry    least    profit    jobs    commercial    workforce    detect    patient    healthy    economic    international    effect    ema    company   

Project "CLINICOVERY" data sheet

The following table provides information about the project.

Coordinator
APPLOADING SL 

Organization address
address: C/ ISAAC NEWTON, S/N, EDIFICIO DISSET MOD C10 PARC
city: PALMA DE MALLORCA
postcode: 7121
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Project website http://apploading.com Isaac Newton street
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.4. (Active ageing and self-management of health)
2. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.3.1.6. (Health care provision and integrated care)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-04-01   to  2018-07-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    APPLOADING SL ES (PALMA DE MALLORCA) coordinator 50˙000.00

Map

 Project objective

The biomedical research is the key to reduce disease burden, and yields economic returns both through improved health gains (a healthy workforce) and through commercial exploitation of research outputs. The increasing disease burden has propelled the pharmaceutical industry to bring up new chemical entities into the market at a higher rate, increasing the number of clinical trials and generating huge quantum of clinical data. As a result, clinical trials are becoming increasingly complex, due the use of multiple data capture modalities (paper and pencil or/and Electronic Data Capture systems (EDC)), which require long implementation time, maintenance, upgrades and high economic investment, the need to evaluate more study endpoints and regulatory compliance with Medical Agencies and the growing number of stakeholders participating in the study. With CLINICOVERY, we will contribute to promote biomedical research in all the target sectors (Public and private) providing a versatile, regulatory compliance (FDA and EMA) cloud based platform that will reduce the implementation time (99%less) and costs (monitoring, price, travels, administrative expenses) and provides the capability to manage a huge and complicate data in large and international clinical trials to reach a faster market approval. Moreover, will be the unique platform in the market that contains a system to detect physiological patient data which gives advance warning of an adverse effect. The exploitation of the CLINICOVERY project will reach the EU countries, as the second region performing more clinical trials and then the Asia Pacific region, with the highest market growth (CAGR around 16% between 2015-2020) and US. In this way, the CLINICOVERY project will not only have a remarkable economic impact on our company (obtaining €7.33 million accumulative profit and ROI of 4.2 and create at least 45 new jobs by 2024), but will also contribute to increase our international presence, by targeting new markets.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CLINICOVERY" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CLINICOVERY" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.4.;H2020-EU.2.1.1.;H2020-EU.2.3.1.;H2020-EU.3.1.6.)

CLINICOVERY (2018)

CLINICOVERY, a versatile, high quality, environmental-friendly, easy to use e-Clinical solution for clinical research

Read More  

PRIDIKTIV (2017)

Pridiktiv - Exploring European expansion through 4 pilot studies

Read More  

JUMPAIR (2018)

Decubitus Ulcers Diseases Diagnoses by means of Smart ICT Anti-Decubitus System based on known Ulcers Activity Biomarkers

Read More